Drug Discovery Partnerships - Challenges and Opportunities
Contributor:
Pharma IQ
Posted: 01/15/2013 12:00:00 AM EST | 0
Posted: 01/15/2013 12:00:00 AM EST | 0
|
The creation of discovery partnerships between pharmaceutical companies and groups such as research organisations, biotech firms and academia is an important part of the industry, paving the way for the development of new drugs and the delivery of more effective treatments.
It is a complex and demanding area, requiring a combination of innovation, investment and efficient collaboration.
...
-
Drugs in Sport: How should the Pharma Industry Respond? -
6 Hot Topics for Disposable Solutions in Biomanufacturing -
Clinical Research “Likely to Return to the UK” Following Change in Patent Law -
High-Throughput Screening: Best Practice, Trends and Challenges -
Retention of Talent in the Pharma Industry -
Drug Discovery Partnerships - Challenges and Opportunities -
Pharma Industry Infonugget #5 - How often did companies review their CMO contracts? -
The Top 10 Pinnacle Moments in the Pharma Industry -
"Haven’t We Changed Enough?": Overcoming Barriers to Continuous Improvement -
3 Reasons Process Excellence Matters to Pharmaceutical Companies
* = required.
Not a member yet? Sign up
You Should Check Out:
Events of Interest
-
Clinically Relevant Drug Transporters
London, UK
September 16- 18, 2013 -
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now -
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches
February 9, 2012
Register Now -
hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing
March 28, 2012
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!